Sarı, S. Et Al. 2022. Potential of nafimidone derivatives against co-morbidities of epilepsy: In vitro, in vivo, and in silico investigations. DRUG DEVELOPMENT RESEARCH , vol.83, no.1 , 184-193.

Sarı, S., Barut, B., Marcinkowska, M., Sabuncuoğlu, S., Avcı, A., Aslan, E. K., ... Özel, A.(2022). Potential of nafimidone derivatives against co-morbidities of epilepsy: In vitro, in vivo, and in silico investigations. DRUG DEVELOPMENT RESEARCH , vol.83, no.1, 184-193.

Sarı, Suat Et Al. "Potential of nafimidone derivatives against co-morbidities of epilepsy: In vitro, in vivo, and in silico investigations," DRUG DEVELOPMENT RESEARCH , vol.83, no.1, 184-193, 2022

Sarı, Suat Et Al. "Potential of nafimidone derivatives against co-morbidities of epilepsy: In vitro, in vivo, and in silico investigations." DRUG DEVELOPMENT RESEARCH , vol.83, no.1, pp.184-193, 2022

Sarı, S. Et Al. (2022) . "Potential of nafimidone derivatives against co-morbidities of epilepsy: In vitro, in vivo, and in silico investigations." DRUG DEVELOPMENT RESEARCH , vol.83, no.1, pp.184-193.

@article{article, author={Suat Sarı Et Al. }, title={Potential of nafimidone derivatives against co-morbidities of epilepsy: In vitro, in vivo, and in silico investigations}, journal={DRUG DEVELOPMENT RESEARCH}, year=2022, pages={184-193} }